Literature DB >> 15636767

Management of infant brachial plexus injuries.

Saleh M Shenaq1, Jamal M Bullocks, Gupreet Dhillon, Rita T Lee, John P Laurent.   

Abstract

Management of brachial plexus injuries is geared toward normalization of limb function, primarily through optimization of nerve regeneration and mechanical increase in elbow flexion and shoulder stabilization. Changes in the skeletal muscles and the osteous structures of the upper extremity are ongoing throughout the course of treatment, mandating continual assessment and aggressive rehabilitation. In patients who present too late for microsurgical intervention, irreversible changes take place in skeletal muscles, highlighting the importance of early referral. However, secondary procedures have been shown to be beneficial in older patients and in those whose primary procedures failed. Further advances in bionics and stem cell therapy may help replace the dynamic functional deficits of obstetric brachial plexus palsy.

Entities:  

Mesh:

Year:  2005        PMID: 15636767     DOI: 10.1016/j.cps.2004.09.001

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  4 in total

1.  Bone discrepancy as a powerful indicator for early surgery in obstetric brachial plexus palsy.

Authors:  Julia K Terzis; Zinon T Kokkalis
Journal:  Hand (N Y)       Date:  2010-05-18

2.  Prognosis following neonatal brachial plexus palsy: an evidence-based review.

Authors:  Susan L Foad; Charles T Mehlman; Mohab B Foad; William C Lippert
Journal:  J Child Orthop       Date:  2009-11-03       Impact factor: 1.548

3.  Three-dimensional humeral morphologic alterations and atrophy associated with obstetrical brachial plexus palsy.

Authors:  Frances T Sheehan; Sylvain Brochard; Abrahm J Behnam; Katharine E Alter
Journal:  J Shoulder Elbow Surg       Date:  2013-12-02       Impact factor: 3.019

4.  Microsurgical outcome in posttraumatic brachial plexus injuries in children.

Authors:  Kanwaljeet Garg; Sumit Sinha; Ashok Kumar Mahapatra; Bhawani Shankar Sharma
Journal:  Childs Nerv Syst       Date:  2013-11-22       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.